Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 340 results for "cadila health"

Cadila Healthcare recalls blood pressure drug in the US
Financial Express

Cadila recalls drug in US

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was ... Calcutta Telegraph, 3 days ago
Cadila Healthcare recalls anti-hypertension drug in US Hindu Business Line, 4 days ago
Cadila Healthcare recalls blood pressure drug in the US Business Standard India, 4 days ago

Cadila recalls chest pain and hypertension tablets in US

Ahmedabad-based Cadila Healthcare's US division has voluntarily initiated recall of 5,400 bottles of atenolol tablets in the United States for failing to meet certain specifications. The drug is used to treat chest pain and hypertension. It is ...
 DNA India3 days ago CADILA HEALTHCARE : recalls chest pain, hypertension tablets in US  4 Traders20 hours ago

Buy Cadila Health, Canara Bk, Capital First: Dharmesh Kant

Dharmesh Kant of India Nivesh Securities is of the view that one can buy Capital First for a target price of Rs 330 and Canara Bank for a target price of Rs 390.
 Money Control1 week ago Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research  Moneycontrol.com2 weeks ago Buy SKS Micro, Bharat Forge, Cadila Health: Dharmesh Kant  Money Control2 months ago

Bull's Eye: Buy Arvind, Cadila Health; short Sesa Sterlite

AK Prabhakar, Independent Advisor advises buying Arvind for a target price of Rs 340 and Sobha Developer for a target price of Rs 488.
 Money Control1 week ago Bull's Eye: India Cements, IRB Infra, Cadila Health, SKS  Money Control2 months ago

Sun Pharmaceutical Industries, Dr Reddy's face US action on price hikes up to 8,000%

Shares of three Indian pharma companies Cadila Healthcare, Dr Reddy's Laboratories and Sun Pharmaceutical Industries on Wednesday fell 5% on news that the US Senate has initiated an investigation against them regarding huge spikes in prices of ...
 DNA India1 week ago Sun, Reddy's face US action on price spikes [DNA : Daily News & Analysis (India)]  Pharmacy Choice1 week ago India's Pharma industry cures but needs Biotech to sustain  CommodityOnline3 weeks ago
Business Standard India

Gilead Licenses Hepatitis Therapy in India Amid Price Criticism

Gilead Sciences Inc. The agreements allow Cadila Healthcare Ltd. (CDH), Cipla Ltd., Hetero Labs Ltd., Mylan Laboratories Ltd. The drug's pricing has drawn criticism from pharmacy benefit managers, as well as questions from U.S. Senators Charles ...
 BusinessWeek1 month ago Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms  Business Standard India1 month ago Generic drugs help US save $239 bn in healthcare spend in 2013  Livemint.com1 month ago Gilead Inks Generic Licensing Pacts to Increase Access to Hepatitis C Treatments in Developing Countries [Health & Beauty Close - Up]  Pharmacy Choice1 month ago
India TV

Zydus gets tentative nod from USFDA to market diabetic tablets

PTI [ Updated 16 Sep 2014, 16:07:55 ] New Delhi: Drug firm Zydus Cadila has received a tentative nod from the health regulator USFDA to market Glipizide tablets, used for treatment of diabetes, in America. "Zydus Cadila has received tentative ...
 India TV1 month ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod  Money Control1 month ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India1 month ago Zydus gets USFDA tentative nod to market anti-diabetic tablets  The Financial Chronicle1 month ago

Focus on stocks, says Dipan Mehta; picks top 5 phama bets

D On specific stocks, he is betting on pharma stocks and likes Ajanta Pharma , IPCA Labs , Cadila Health , Torrent Pharma and Alembic Pharma . From the FMCG space, he is cautious on cigarette major ITC on the back of tobacco business-related ...
 Moneycontrol.com2 months ago Pharma stocks outperform equity benchmarks, rally 2-14%  Moneycontrol.com2 months ago Pharmexcil to celebrate 10 years of success on Sept 18 & 19 in Hyderabad  PharmaBiz1 month ago

Cadila Health at new high on USFDA nod for anti-viral drug

Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.
 Money Control2 months ago
Business Standard

Zydus Cadila gets USFDA nod for kidney stones tablets

Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidney stones. Zydus Cadila has received the final approval from the United States Food and Drug Administration ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less